Integrating monoclonal antibodies into the management of mantle cell lymphoma

被引：8

作者：

Berinstein, NL ^{[1
]}

Mangel, J ^{[1
]}

机构：

[1] Toronto Sunnybrook Reg Canc Ctr, Adv Therapeut Program, Toronto, ON M4N 3M5, Canada

来源：

SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 01期

关键词：

D O I：

10.1053/j.seminoncol.2003.12.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2 / 6

页数：5

共 18 条

[1] Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease [J].

Andersen, NS ;

Donovan, JW ;

Borus, JS ;

Poor, CM ;

Neuberg, D ;

Aster, JC ;

Nadler, LM ;

Freedman, AS ;

Gribben, JG .

BLOOD, 1997, 90 (10) :4212-4221

[2] Mantle-cell lymphoma [J].

Barista, Ibrahim ;

Romaguera, Jorge E. ;

Cabanillas, Fernando .

LANCET ONCOLOGY, 2001, 2 (03) :141-148

[3] High-dose chemotherapy with hematopoietic stem cell transplantation in patients with mantle cell or diffuse centrocytic non-Hodgkin's lymphomas:: a single center experience on 18 patients [J].

Blay, JY ;

Sebban, C ;

Surbiguet, C ;

Ouachée, M ;

Philip, I ;

Philip, T ;

Biron, P .

BONE MARROW TRANSPLANTATION, 1998, 21 (01) :51-54

[4]

Chan WC, 1997, BLOOD, V89, P3909

[5]

DREYLING MH, 2002, HEMATOL J, V4, P150

[6] European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma [J].

Foran, JM ;

Rohatiner, AZS ;

Cunningham, D ;

Popescu, RA ;

Solal-Celigny, P ;

Ghielmini, M ;

Coiffier, B ;

Johnson, PWM ;

Gisselbrecht, C ;

Reyes, F ;

Radford, JA ;

Bessell, EM ;

Souleau, B ;

Benzohra, A ;

Lister, TA .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) :317-324

[7] High-dose chemoradiotherapy and anti-B-cell monoclonal antibody purged autologous bone marrow transplantation in mantle-cell lymphoma: No evidence for long-term remission [J].

Freedman, AS ;

Neuberg, D ;

Gribben, JG ;

Mauch, P ;

Soiffer, RJ ;

Fisher, DC ;

Anderson, KC ;

Andersen, N ;

Schlossman, R ;

Kroon, M ;

Ritz, J ;

Aster, J ;

Nadler, LM .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :13-18

[8] Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen) [J].

Gianni, AM ;

Magni, M ;

Martelli, M ;

Di Nicola, M ;

Carlo-Stella, C ;

Pilotti, S ;

Rambaldi, A ;

Cortelazzo, S ;

Patti, C ;

Parvis, G ;

Benedetti, F ;

Capria, S ;

Corradini, P ;

Tarella, C ;

Barbui, T .

BLOOD, 2003, 102 (02) :749-755

[9] Rituximab: Enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphoma [J].

Gisselbrecht, C ;

Mounier, N .

SEMINARS IN ONCOLOGY, 2003, 30 (01) :28-33

[10]

Haas R, 1996, LEUKEMIA, V10, P1975

← 1 2 →